New Drugs FDA Approves Camzyos (mavacamten) for the Treatment of Symptomatic NYHA Class II-III Obstructive Hypertrophic Cardiomyopathy 3 years ago
New Drugs Rinvoq (upadacitinib) Approved by U.S. FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis 3 years ago
Pharma Industry News Sanofi and McLaren Racing come together to maximise performance and operational excellence 3 years ago
Pharma Industry News Sanofi and McLaren Racing come together to maximise performance and operational excellence 3 years ago
Pharma Industry News Insulin glargine meets primary endpoint in Sanofi’s type 1 diabetes study 3 years ago